Matches in Nanopublications for { ?s ?p "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1230561.RAbthsQFm94Gdewtz7dsu88QQV0boHwFylVMeZ6WWgqEc130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230561.RAbthsQFm94Gdewtz7dsu88QQV0boHwFylVMeZ6WWgqEc130_provenance.
- NP1230558.RAigp0lJ9XYdrUwIqNmjhnNyhoarjQwAHDGkrhmORXSdM130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230558.RAigp0lJ9XYdrUwIqNmjhnNyhoarjQwAHDGkrhmORXSdM130_provenance.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.
- NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230560.RA5V6_1RWNJ2ONIazMqbNwVK5WkuT139ZypvjfTJaZKpU130_provenance.